Experiments on mouse models of melanoma, B-cell lymphoma, and sarcoma reveal that B-cell and B-cell-derived cytokine IL-10 can suppress anti-tumor immune responses [75]. This evidence concerns the gene IL10 and B-cell non-Hodgkin lymphoma.